These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
517 related items for PubMed ID: 18752153
21. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. Hattab EM, Koch MO, Eble JN, Lin H, Cheng L. J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733 [Abstract] [Full Text] [Related]
22. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy. Rodriguez-Covarrubias F, Larre S, De La Taille A, Abbou CC, Salomon L. BJU Int; 2008 Feb; 101(3):305-7. PubMed ID: 17941921 [Abstract] [Full Text] [Related]
23. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients. Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC. Cancer; 2003 Mar 01; 97(5):1225-33. PubMed ID: 12599229 [Abstract] [Full Text] [Related]
24. Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer. Servoll E, Saeter T, Vlatkovic L, Lund T, Nesland J, Waaler G, Axcrona K, Beisland HO. BJU Int; 2012 May 01; 109(10):1489-94. PubMed ID: 21933333 [Abstract] [Full Text] [Related]
25. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy. Shikanov S, Marchetti P, Desai V, Razmaria A, Antic T, Al-Ahmadie H, Zagaja G, Eggener S, Brendler C, Shalhav A. BJU Int; 2013 Apr 01; 111(4):559-63. PubMed ID: 22759270 [Abstract] [Full Text] [Related]
26. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT. J Urol; 2008 May 01; 179(5 Suppl):S47-51. PubMed ID: 18405751 [Abstract] [Full Text] [Related]
27. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer. Mizuno R, Nakashima J, Mukai M, Okita H, Kosugi M, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Oya M. BJU Int; 2009 Nov 01; 104(9):1215-8. PubMed ID: 19389009 [Abstract] [Full Text] [Related]
28. Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer. Huang JG, Pedersen J, Hong MK, Harewood LM, Peters J, Costello AJ, Hovens CM, Corcoran NM. BJU Int; 2013 May 01; 111(6):921-7. PubMed ID: 23350712 [Abstract] [Full Text] [Related]
29. Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk disease. Corcoran NM, Hovens CM, Metcalfe C, Hong MK, Pedersen J, Casey RG, Peters J, Harewood L, Goldenberg SL, Costello AJ, Gleave ME. BJU Int; 2012 Sep 01; 110(6):821-7. PubMed ID: 22257140 [Abstract] [Full Text] [Related]
30. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy? Jones TD, Koch MO, Bunde PJ, Cheng L. BJU Int; 2006 Mar 01; 97(3):480-4. PubMed ID: 16469012 [Abstract] [Full Text] [Related]
31. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Kausik SJ, Blute ML, Sebo TJ, Leibovich BC, Bergstralh EJ, Slezak J, Zincke H. Cancer; 2002 Sep 15; 95(6):1215-9. PubMed ID: 12216087 [Abstract] [Full Text] [Related]
32. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy. Khatami A, Hugosson J, Wang W, Damber JE. Scand J Urol Nephrol; 2009 Sep 15; 43(1):12-8. PubMed ID: 18949633 [Abstract] [Full Text] [Related]
33. Does year of radical prostatectomy independently predict outcome in prostate cancer? Mitchell RE, Shah JB, Olsson CA, Benson MC, McKiernan JM. Urology; 2006 Feb 15; 67(2):368-72. PubMed ID: 16461087 [Abstract] [Full Text] [Related]
34. Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: a detailed assessment of margin extent and location. Sammon JD, Trinh QD, Sukumar S, Ravi P, Friedman A, Sun M, Schmitges J, Jeldres C, Jeong W, Mander N, Peabody JO, Karakiewicz PI, Harris M. Urol Oncol; 2013 Nov 15; 31(8):1470-6. PubMed ID: 22534086 [Abstract] [Full Text] [Related]
38. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study. Wiegel T, Lohm G, Bottke D, Höcht S, Miller K, Siegmann A, Schostak M, Neumann K, Hinkelbein W. Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1009-16. PubMed ID: 18963539 [Abstract] [Full Text] [Related]
40. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. Chun FK, Briganti A, Antebi E, Graefen M, Currlin E, Steuber T, Schlomm T, Walz J, Haese A, Friedrich MG, Ahyai SA, Eichelberg C, Salomon G, Gallina A, Erbersdobler A, Perrotte P, Heinzer H, Huland H, Karakiewicz PI. BJU Int; 2006 Dec 15; 98(6):1204-9. PubMed ID: 17034506 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]